APR is a Swiss independent pharma company focused on development and global commercialization of innovative, research-driven products designed to address unmet needs in specialized therapeutic areas and rare diseases.
APR combine pharmaceutical development expertise with proprietary drug delivery technologies to realize solutions that meaningfully improve the lives of people with rare diseases and empower families through novel approaches to disease management.
A diverse and balanced portfolio of revenue-generating products in all major markets is complemented by a robust pipeline of innovative products at different stages of development for the treatment of recessive metabolic disorders, as well as rare dermatological and ocular diseases.
Products are directly commercialized by APR through inhouse sales and marketing teams in strategically important countries across Europe and a growing worldwide network of commercial partners.
Location: Switzerland, Ticino, Balerna
Member count: 11-50
Founded date: 1990
Investors 1
| Date | Name | Website |
| - | HBM Partne... | hbmpartner... |
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 13.05.2021 | Initiated ... | Product recently cleared in EU... | - | - | en.prnasia... |
| 12.05.2021 | Initiated ... | BALERNA, Switzerland, May 12... | - | - | prnewswire... |
| 04.05.2021 | RELIEF THE... | Acquisition would further dive... | - | - | marketscre... |
| 31.03.2015 | Applied Ph... | APR Applied Pharma Research s.... | Switzerlan... | - | finsmes.co... |
| 06.06.2012 | Bright Tec... | Normal 0 21 false false fals... | - | - | startuptic... |